Huntington's disease: From basic science to therapeutics

Affiliations

¹ Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
² Discipline of Neuroscience and Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Editorial

Carlos Cepeda et al. CNS Neurosci Ther. 2018 Apr.

. 2018 Apr;24(4):247-249.

doi: 10.1111/cns.12841.

¹ Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
² Discipline of Neuroscience and Department of Anatomy and Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

No abstract available

References

1. The Huntington's Disease Collaborative Research Group . A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993;72:247‐249. - PubMed
1. DiFiglia M. Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 1990;13:286‐289. - PubMed
1. Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet MF. Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect. Trends Neurosci. 2004;27:691‐697. - PubMed
1. Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493‐506. - PubMed
1. Reiner A, Dragatsis I, Zeitlin S, Goldowitz D. Wild‐type huntingtin plays a role in brain development and neuronal survival. Mol Neurobiol. 2003;28:259‐276. - PubMed